Protein Labeling Market Report 2025

This Protein Labeling market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The protein labeling market size has grown rapidly in recent years. It will grow from $2.58 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increasing demand for protein-based therapeutics, growing adoption of proteomics research, expanding range of applications for protein labeling, rising awareness of the benefits of protein labeling, increasing availability of skilled labor, increasing prevalence of chronic diseases.

The protein labeling market size is expected to see rapid growth in the next few years. It will grow to $4.36 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to personalized medicine, point-of-care (POC) testing, growth in proteomics, increased funding and investment in life sciences, rising healthcare expenditure. Major trends in the forecast period include advances in protein labeling technologies, quantum dots and nanoparticles, multiplexing and high-throughput labeling, biorthogonal labeling, integration of artificial intelligence (ai), sustainable labeling reagents, drug development.

Increased investment in proteomics and genomics research is fueling growth in the protein labelling reagents market. Proteomics, focusing on a cell, tissue, or organism's protein content, relies on pre-separation and analysis protein labelling methods. Notably, the National Institutes of Health (NIH) allocated $37 billion for life sciences research, emphasizing molecular-level studies to comprehend disease development, identify biomarkers, and pinpoint disease-related genes or proteins. Additionally, the Novo Nordisk Foundation granted up to $1.5 million to the University of Copenhagen for a mass spectrometry facility, marking a pivotal advancement in protein research. This increased R&D spending is driving market expansion.

The expansion of clinical research is anticipated to drive the growth of the protein labeling market in the coming years. Clinical research encompasses a field of medical and scientific inquiry that involves studying human subjects to enhance healthcare, diagnose diseases, and develop new treatments or therapies. It plays a crucial role in the development and validation of protein labeling techniques, which are vital for understanding disease mechanisms, diagnosing conditions, creating therapeutics, and monitoring treatment responses. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association focused on enhancing the pharmaceutical sector in the UK, reported a slight increase in clinical trials initiated annually, rising by 4.3% from 394 trials in 2021 to 411 in 2022. Consequently, the growth of clinical research is contributing to the expansion of the protein labeling market.

Companies within the protein labelling market are intensifying product innovation through strategic collaborations. In a bid to remain competitive, firms are leveraging partnerships to foster innovation and share expertise. Collaborations between companies and academic/research institutions have seen a marked rise. For example, enGenes Biotech GmbH announced a collaboration with ACIB GmbH specifically for protein labelling, indicative of this increasing trend in collaborative efforts.

Major players in the protein labelling market are actively innovating with new technologies like KerryNutri Guide to bolster their market position. KerryNutri Guide, a technology aiding producers in enhancing nutritional profiles and adhering to front-of-pack regulations, was launched by Kerry Group plc in December 2022. The tool evaluates products based on calorie, fat, sugar, fiber, protein, and salt content, guiding users toward higher-rated nutritional options, akin to front-of-pack nutrition labelling methods.

In January 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company acquired PeproTech Inc for a deal amount of $1.85 billion. This acquisition aims to strengthen Thermo Fisher Scientific's ability to meet the needs of the rapidly expanding cell and gene therapy sector. Recombinant proteins, developed and produced by PeproTech, are employed in a variety of applications, such as cell culture, immunology, and neuroscience research. Thermo Fisher Scientific's position in the life sciences sector is anticipated to be strengthened by the acquisition of PeproTech, which will also broaden its product line. PeproTech Inc is a US-based developer and manufacturer of recombinant proteins.

Protein labeling involves the application of molecular tags to detect or isolate specific proteins and their binding partners. In biological research, three primary categories of protein labels are commonly used: biotin, enzyme conjugates, and fluorescence probes.

The main products within protein labeling encompass reagents, proteins, enzymes, probes or tags, and monoclonal antibodies. Monoclonal antibodies are generated through the cloning of a single white blood cell, enabling the tracing of subsequent antibodies back to a single parent cell. Various labeling methods include in-vitro labeling and in-vivo labeling, which find application in cell-based assays, fluorescence microscopy, immunological techniques, mass spectrometry, and protein micro assays. These methods play a crucial role in detecting and analyzing proteins, aiding in research across diverse scientific disciplines.

The protein labelling market research report is one of a series of new reports that provides protein labelling market statistics, including the industry's global market size, regional shares, competitors with a protein labelling market share, detailed protein labelling market segments, market trends and opportunities, and any further data you may need to thrive in the protein labelling industry. This protein labelling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Major companies operating in the protein labeling market include Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., GE HealthCare Technologies Inc., F. Hoffmann-La Roche AG, Agilent Technologies Inc., BIO-RAD LABORATORIES, Kirkegaard & Perry Laboratories, LI-COR Inc., Kaneka Corporation, Promega Corporation, Eurogentec S.A., Luminex Corporation, New England Biolabs Inc., Seracare Life Sciences Inc., Abcam plc., ZEDIRA GmbH, NanoTemper Technologies GmbH, TriLink BioTechnologies LLC., Waters Corporation, AMETEK Inc., HORIBA Ltd., Spectris plc., METTLER TOLEDO International Inc., Shimadzu Corporation, Hitachi High-Tech Corporation, Attana AB, Affinité Instruments, Biosensing Instruments.

North America was the largest region in the protein labelling market in 2024. The regions covered in the protein labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the protein labeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The protein labelling market includes revenues earned by entities by detecting or purifying the labelled protein and its binding partners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.